Year : 2017 | Volume
: 1 | Issue : 1 | Page : 2--10
Asthma: What's new, and what should be old but is not!
Department of Paediatrics, Imperial College; Department of Paediatric Respirology, National Heart and Lung Institute; Royal Brompton and Harefield NHS Foundation Trust, London, UK
Asthma is a common condition, which is commonly, badly diagnosed and badly treated, leading to unnecessary morbidity and even death in childhood, despite which complacency about management at all levels of care persists. Asthma is an umbrella term like anaemia and arthritis and should not be used as an unqualified diagnosis. It is suggested that airway disease should be deconstructed into treatable and untreatable components, such as fixed and variable airflow obstruction and airway inflammation and infection. Every effort should be made to make an objective diagnosis, and treatment should be individualised accordingly. Objective testing for airway inflammation may include determination of atopic status, blood eosinophil count and exhaled nitric oxide; physiological testing includes peak flow measurement, comprising response to exercise and short-acting μ-2 agonists. Most school-age atopic children with recurrent wheeze respond well to low-dose inhaled corticosteroids if these are regularly and correctly administered. The provision of an asthma plan is mandatory. If response is poor, rather than uncritically escalating therapies, a review of adherence and any adverse environmental factor should be considered. Asthma attacks are a red flag sign of a bad prognosis, and should prompt a full review, and changes in the asthma plan as necessary. Also, regular reviews of progress and treatment need are mandatory, even in the well child with asthma. In all contexts, the importance of getting the basic rights cannot be overemphasised; still, asthma deaths are attributed to neglect of this principle. Other issues discussed in this review include the approach to the child who is breathless on exercise and the diagnosis of exercise-induced laryngeal obstruction; the so-called habit/honk cough; the problem of breathlessness and airway disease in the obese child, including the airway as the target of systemic inflammation; and the problem of 'asthma' complicating other airways diseases such as cystic fibrosis and extrapulmonary diseases such as sickle-cell anaemia. Overall, the main message of this review is that it should never be forgotten that asthma is a disease which kills children and should always be taken seriously.
Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London SW3 6NP
|How to cite this article:|
Bush A. Asthma: What's new, and what should be old but is not!.Pediatr Respirol Crit Care Med 2017;1:2-10
|How to cite this URL:|
Bush A. Asthma: What's new, and what should be old but is not!. Pediatr Respirol Crit Care Med [serial online] 2017 [cited 2023 Mar 26 ];1:2-10
Available from: https://www.prccm.org/article.asp?issn=2543-0343;year=2017;volume=1;issue=1;spage=2;epage=10;aulast=Bush;type=0